AstraZeneca Rejects Pfizer's New Bid, Chairman Says

AstraZeneca Rejects Pfizer's New Bid, Chairman Says Play

May 19 (Bloomberg) -- AstraZeneca Plc Chairman Leif Johansson talks about the company's rejection of Pfizer Inc.'s raised acquisition bid. Pfizer's latest offer of 69.4 billion pounds ($117 billion) may be a maneuver around AstraZeneca’s management, pitched publicly to pressure the company to enter formal negotiations. (This is an excerpt of the full interview. Source: Bloomberg)

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus